Evidence map›Paper›PMID 27438349›Full record

ReviewArchives of toxicology2017

Protein bio-corona: critical issue in immune nanotoxicology.

Monica Neagu, Zoi Piperigkou, Konstantina Karamanou, Ayse Basak Engin, Anca Oana Docea, Carolina Constantin, Carolina Negrei, Dragana Nikitovic, Aristidis Tsatsakis

Abstract readReview
In one paragraph

Review in Archives of toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Modification of Gold Nanoparticles Provides Antioxidant and Anti-Tumor Properties.Asian Pacific journal of cancer prevention : APJCP · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Monica NeaguImmunology Department, "Victor Babes" National Institute of Pathology, Bucharest, Romania.
Zoi PiperigkouLaboratory of Biochemistry, Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Department of Chemistry, University of Patras, Patras, Greece.
Konstantina KaramanouLaboratory of Biochemistry, Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Department of Chemistry, University of Patras, Patras, Greece.
Ayse Basak EnginDepartment of Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Anca Oana DoceaDepartment of Toxicology, Faculty of Pharmacy University of Medicine and Pharmacy Craiova, Craiova, Romania.
Carolina ConstantinImmunology Department, "Victor Babes" National Institute of Pathology, Bucharest, Romania.
Carolina NegreiDepartment of Toxicology, Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Dragana NikitovicLaboratory of Anatomy-Histology-Embryology, Medical School, University of Crete, Heraklion, Greece.
Aristidis TsatsakisDepartment of Toxicology and Forensic Sciences, Medical School, University of Crete, Heraklion, Greece. aris@med.uoc.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the expansion of the nanomedicine field, the knowledge focusing on the behavior of nanoparticles in the biological milieu has rapidly escalated. Upon introduction to a complex biological system, nanomaterials dynamically interact with all the encountered biomolecules and form the protein "bio-corona." The decoration with these surface biomolecules endows nanoparticles with new properties. The present review will address updates of the protein bio-corona characteristics as influenced by nanoparticle's physicochemical properties and by the particularities of the encountered biological milieu. Undeniably, bio-corona generation influences the efficacy of the nanodrug and guides the actions of innate and adaptive immunity. Exploiting the dynamic process of protein bio-corona development in combination with the new engineered horizons of drugs linked to nanoparticles could lead to innovative functional nanotherapies. Therefore, bio-medical nanotechnologies should focus on the interactions of nanoparticles with the immune system for both safety and efficacy reasons.

Indexed as

Adaptive ImmunityAnimalsHumansHydrophobic and Hydrophilic InteractionsImmunity, InnateNanomedicineNanostructuresParticle SizeProtein CoronaProtein CoronaBio-coronaImmunological identityNanoparticle

Identifiers

PMID27438349
PMCPMC5316397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.